Thank you for submitting your manuscript for consideration by the EMBO Journal and my apologies for the slight delay in communicating our decision to you. Your study has now been seen by three referees whose comments are shown below.
As you will see from the reports, all referees express interest in the findings reported in your manuscript; however, the also raise a number of major and minor points that will have to be addressed in full before they can support publication of a revised manuscript.
In particular, I would encourage you to develop/address the following points: -> Please provide further experimental data to clarify the basis for AGO6-selectivity in small RNA recognition (as pointed out by refs #1 and #3); please also address a possible contribution from AGO2 in the pathway (ref #3 point 2) We generally allow three months as standard revision time. As a matter of policy, competing manuscripts published during this period will not negatively impact on our assessment of the conceptual advance presented by your study. However, we request that you contact the editor as soon as possible upon publication of any related work, to discuss how to proceed. Should you foresee a problem in meeting this three-month deadline, please let us know in advance and we may be able to grant an extension.
Thank you for the opportunity to consider your work for publication. I look forward to your revision.
REFEREEE REPORTS:
Referee #1:
In the manuscript by McCue and colleagues, the authors show that transcriptionally active transposable elements (TEs) produce siRNAs that incorporate into AGO6 complexes in order to guide RdDM and transcriptionally silence TEs in reproductive precursor cells.
To investigate the establishment of RDR6-dependent RdDM in transcriptionally active TEs, the authors focus on the Athila family of LTR retrotransposons in Arabidopsis thaliana. In order to remove the effect of maintenance methylation pathways, which the authors state can obstruct the visualization of the establishment of DNA methylation because they occur simultaneously at TEs via RdDM, and to better distinguish the Pol IV-RdDM and RDR6-RdDM pathways, the authors conduct their studies in ddm1 mutant plants combined with other mutants including a ddm1 dcl3 double mutant and a ddm1 polIV rdr6 triple mutant, which does not accumulate Athila6A siRNAs. In ddm1 mutants, a SWI/SNF ATPase family member that participates in chromatin compaction is impaired, many chromatin areas containing TEs de-condense, the distribution of methylation changes on a global scale and many TEs become transcriptionally active. For the TSS region of the Athila6A sub-family, in contrast to the levels of symmetrical CG and CHG methylation, the levels of CHH asymmetrical methylation in wild-type plants is low and is independent of the DNA methyltransferase DRM2, but instead is maintained by the methyltransferase CMT2. However, in ddm1 mutants, Athila6A becomes transcriptionally active and DRM2-dependent.
regions from which these siRNAs derive with RDR6-RdDM. They also confirm and refine the role of AGO6 in TAS3a-derived and SimpleHat2-derived siRNA binding. The authors go on to show using ChIP that Athila6A siRNAs direct AGO6 to chromatin at the Athila6A TSS region that is targeted by RdDM and that this association is dependent on Athila6A transcription, the presence of siRNAs and Pol V at the TSS, even when the Athila TE is transcribed.
To identify global targets of DR6-RdDM, the authors mapped their FLAG-AGO6-IP small RNA sequencing data to the entire Arabidopsis genome and combined this with bisulfite DNA methylation data and found only a few enriched regions corresponding to intergenic sequences in WT plants (specifically the AthPOGO group of transposons), but identified many transcriptionally active TE regions in ddm1 mutants that are enriched for AGO6, 21-22nt siRNAs and RDR6-dependent CHH methylation. From these data, the authors conclude that the AGO6-RDR6-RdDM pathway primarily targets long and centromeric transcriptionally active TEs and TAS loci. Finally, the authors show that that RDR6-RdDM primarily functions to establish TE methylation in the gamete precursor cells, due at least in part to the restricted expression of AGO6.
Overall, the experiments are well executed, the data is interesting although not completely novel as many of the results have been previously shown or inferred. However, the conclusions are fairly well supported by these new sets of experiments, allowing the authors to better distinguish the pathways of Pol IV-RdDM and RDR6-RdDM and to confirm the role of AGO6.
However, the overall importance of the RDR6-RdDM pathway in WT plants is still unclear, with the exception of perhaps the AthPOGO group of TEs) since nearly all of the data pertains to ddm1 mutants. It would be good for the authors to add a few sentences to the discussion concerning the phenotypic analysis of ago6 mutants, which could help to explain its role in RdDM. Furthermore, it is still unclear how AGO6 selects the siRNAs to which it binds. These characteristics are key features to understand this RDR6-RdDM-AGO6-dependent mechanism and should be experimentally developed further.
Referee #2:
The manuscript by McCue et al. describes the role of Argonaute 6 (AGO6) in the so-called RDR6-RdDM, an alternate RNA-directed DNA methylation pathway that differs from the canonical RdDM pathway in that it requires RDR6 rather than RDR2. This lab showed previously that when the Athila family of TEs is reactivated (such as in the ddm1 background), RDR6-RdDM and canonical RdDM act together to cause DNA methylation at the TEs. But the AGO effector in RDR6-RdDM was unknown.
In this study, the authors found that 1) 21-22nt siRNAs are associated with RDR6-RdDM, 2) these siRNAs are bound by AGO6, 3) AGO6 is genetically required for RDR6-RdDM in addition to its previously known function in canonical RdDM, and 4) 21-22nt siRNAs and Pol V-dependent transcripts recruit AGO6 to target loci. These observations help define the silencing pathway that operates at transcriptionally active TEs to lead to their methylation. In addition, the authors showed that this pathway is only active in inflorescences, thus implicating a potential role of this pathway during plant reproduction. Overall, the work reported was of high technical quality, and the findings are likely to high impacts on our understanding of how transcriptionally active TEs could be eventually silenced in plants.
Below are some minor comments for the authors to consider.
1.They examined siRNA accumulation and DNA methylation at Athila in ddm1 dcl3, ddm1 pol IV, and ddm1 polIV rdr6 backgrounds in order to associate RDR6 and 21-22nt siRNAs with CHH methylation. The genotypes examined were not ideal, as one has to make some inferences to reach conclusions. It would be best to examine ddm1 rdr6 and ddm1 dcl3 rdr6.
2. It is unclear the scale at which the RDR6-RdDM pathway operates to silence TEs in the genome. The study touched upon this by examining the regions that produce AGO6-bound 21-22 nt siRNAs as well as the regions that require RDR6 for CHH methylation (Fig 5) . They found thousands of genomic tiles that have 21-22 nt siRNAs bound by AGO6 in the ddm1 background, but only hundreds of tiles that require RDR6 for CHH methylation in the ddm1 background. The authors should discuss what this means for the contributions of AGO6 or RDR6 to RDR6-RdDM.
It would be also nice if the authors could integrate their AGO6-siRNA data with available genomics data to derive better insights into the RDR6-RdDM pathway. For example, does RDR6-RdDM operate mainly at CMT2-targeted loci? 3. It is surprising that the authors did not discuss whether or how the RDR6-RdDM pathway is related to the germline-vegetative cell communication that is thought to involve the activation of TEs in the vegetative nucleus and the transfer of small RNAs from the vegetative cell to the sperm cells. Given the existing methylome data from sperm and vegetative nucleus, it should be examined whether Althila methylation occurs in the sperm or vegetative nuclei, and whether AGO6 is specifically expressed in one cell. Since the authors show that the pathway operates only in inflorescences, it would be nice to relate their findings to their earlier findings about the differential regulation of DNA methylation and siRNA biogenesis in the reproductive cells.
Referee #3:
McCue et al. EMBOJ-2014-89499 "ARGONAUTE 6 is recruited to chromatin by transposable element mRNA degradation products to establish DNA methylation". In the present paper, the authors keep on their work to understand how a transcriptionnally active TE becomes silenced at chromatin level in Arabidopsis. Previous work from Slotkin's lab described the involvement of 21-22 nt long siRNA as well as the action of RDR6 in the transition of TE from an active to inactive states of expression (Nuthikattu et al. 2013 genetic evidences reinforcing the implication of AGO6 in both PolIV-and RDR6-RdDM. They show that ago6 mutation does not affect the production of Athila6A siRNA and that AGO6 loads preferentially 24 nt-long Athila6A siRNA in a silenced state background and 21/22 nt-long siRNA when the TE is transcriptionnally active. Correlation between 21-22nt siRNA AGO6 loading enrichment and effect on DNA methylation support the action of AGO6 in RDR6-RdDM pathway (Fig1A and 2H,2I). The authors then provide elements to link physically AGO6 to RDR6-RdDM target using CHIP experiments, demonstrating siRNA-dependent association of AGO6, but also PolV, at Athila6A TSS region when the TE is expressed. The authors widen their analysis to genome scale, showing that ddm1 mutant background mainly favors the loading in AGO6 of TEassociated siRNA matching to RDR6-RdDM dependent CHH methylation sites (21-22 nt siRNA in ddm1; fig4A-B). The last part of this paper propose a developmental window for RDR6-RdDM activity, based mainly on AGO6 expression profil (pAGO6::AGO6-GFP). Although AGO6 distribution is clear (leaf versus inflorescences in Fig5C and emerging sepals and floral meristem cells in Fig5H) ; the enrichment of DNA methylation in these cells (fig5I) is not so obvious. This is an interesting work that extends the previous analysis performed by the same lab on RDR6-RdDM, therefore giving a more complete picture of this novel epigenetic pathway in plants. The paper is noteworthy for the technical approach, the quality of the work, and the potential new insights regarding the role of AGO6 in RDR6-RdDM. For all these reasons, I think that this is an interesting work worth publishing in EMBO J.
Major comments 1) Is there any bias in 5' base in AGO6 21-22 nt loaded siRNA? 2) We can regret to do not have any molecular or genetic analysis data for AGO2. 3) How the authors can explain the difference in the ratio of 21/22 nt observed between the Flag IP done on Flag-AGO6/ago6/ddm1 ( fig 2E) and the IP performed in ddm1 using native anti-AGO6 antibody (figE3F)? This is quite striking in Athila6A LTR TSS and the first half region of gag/pol unit. 4) The developmental window assigned to RDR6-RdDM action in reproductive system is not strongly supported by data. The expression of Athila6A in ddm1 leaf compared to inflorescence could be a control to add. We thank Reviewer #1 for their thoughtful review of our work and below comments.
However, the overall importance of the RDR6-RdDM pathway in WT plants is still unclear, with the exception of perhaps the AthPOGO group of TEs) since nearly all of the data pertains to ddm1 mutants.
We have added some discussion about the low / limited role of RDR6-RdDM in wild-type Arabidopsis plants to the discussion section. We do not believe that the RDR6-RdDM pathway does much in wild-type plants. The RDR6-RdDM methylation of TAS loci does not alter TAS gene expression (Wu et al., 2012) , and we only detect it functioning on one small family of TEs (Pogo) in wt Col. Lastly, very few genome regions produce 21-22nt siRNAs that are enriched in AGO6 in wt Col, and even fewer of these results in RDR6-dependent methylation ( Figure 4A-B) . Thus, we have attempted to be very clear in the Discussion section that RDR6-RdDM plays a very limited role in wt Col cells. In contrast, this pathway plays a larger and more significant role when TEs are transcriptionally active.
It would be good for the authors to add a few sentences to the discussion concerning the phenotypic analysis of ago6 mutants, which could help to explain its role in RdDM.
We have added sentences about the phenotype of ago6 mutants to the discussion section.
Furthermore, it is still unclear how AGO6 selects the siRNAs to which it binds.
We have added data to Figure 2 on the selectivity of AGO6 for particular small RNAs, and we have expanded our analysis in the Results section and expanded this section of the Discussion. Although this provides some evidence that AGO6 can incorporate siRNAs produced from some Pol II transcripts and not others, Argonaute protein selectivity is hotly debated field, and the scale of experiments to fully and properly determine how AGO6 distinguishes particular small RNAs (or siRNA-generating mRNAs) from a vast pool would constitute a completely separate study / paper and are beyond the scope of time limit for this three month revision period. Figure 3 .
In addition, we have made several attempts to generate a ddm1/dcl3/rdr6 triple mutant, but to date no labs have been able to create this triple mutant combination. We have screened hundreds of plants, suggesting that this particular triple mutant combination with transcriptionally active TEs (via ddm1), no 24nt siRNA production (via dcl3) and no 21-22nt siRNA production (via rdr6) has a particularly severe (if not lethal) phenotype. However, we worked for several years to obtain a very similar genotype, the ddm1/pol4/rdr6 triple mutant, which has very few total TE siRNAs, and is shown in Figure 1 
It is unclear the scale at which the RDR6-RdDM pathway operates to silence TEs in the genome. The study touched upon this by examining the regions that produce AGO6-bound 21-22 nt siRNAs as well as the regions that require RDR6 for CHH methylation (Fig 5). They found thousands of genomic tiles that have 21-22 nt siRNAs bound by AGO6 in the ddm1 background, but only hundreds of tiles that require RDR6 for CHH methylation in the ddm1 background. The authors should discuss what this means for the contributions of AGO6 or RDR6 to RDR6-RdDM.
We have redone Figures 4A-B to take a more unbiased approach to demonstrating that AGO6 incorporation of 21-22nt siRNAs drives RDR6-dependent CHH methylation. At the same time, we agree with Reviewer #2 that it is difficult to judge the genome-wide scale of this contribution to methylation. We have elaborated on why not all AGO6 enrichment of small RNAs leads to RDR6-RdDM. First, a Pol V transcript is also required for RdDM. Second, the exact regions of the genome that are targeted by RDR6-RdDM (highly repetitive centromeric long TEs) are the precise regions where whole-genome bisulfite sequencing has the worst mapping and coverage. In addition, we are currently defining the RDR6-RdDM pathway as requiring RDR6, so there is a 100% contribution of RDR6 to RDR6-RdDM. For AGO6, the genomic regions that undergo RDR6-RdDM have been well characterized (TAS3a, Athila6, AtEnSPM, AtPogo). The dependence of their methylation on AGO6 is greater to or equal to the dependence on RDR6, likely because AGO6 also plays a key role in Pol IV-RdDM. Therefore, for these well-characterized RDR6-RdDM regions, at least in inflorescence tissue, there seems to also be a 100% dependence on AGO6. This point has been clarified in the Discussion section.
It would be also nice if the authors could integrate their AGO6-siRNA data with available genomics data to derive better insights into the RDR6-RdDM pathway. For example, does RDR6-RdDM operate mainly at CMT2-targeted loci?
We have experimentally integrated our AGO6-siRNA data with CMT2-targeted loci as well as other publically available Arabidopsis genome-wide methylation datasets. We have added a new Expanded View Figure (E4 ) that details the genome-wide association between the small RNAs enriched in AGO6 and the types of DNA methylation (CG, CHG, CHH) in the wt Col epigenome. Although these results are interesting and suggestive, they are merely correlations and because of several technical issues (discussed below) we find that none of the correlations are strong enough to warrant their display in the main manuscript body.
One reason complicating the quantification of these correlations is the fact that all of these analyses are done in different tissues (CMT2 bisulfite sequencing in seedling and leaf), and no other dataset includes the ddm1 genotype (besides the ddm1 bisulfite data shown in Figure 4A-B) . Lastly, the mapping of bisulfite sequencing reads was performed very differently in all of these experiments, and this leads to very different coverage of TEs in these various datasets. We feel that showing these weak big-data correlations and loosely speculating beyond that would draw away from the concrete results and proven mechanism of this manuscript.
It is surprising that the authors did not discuss whether or how the RDR6-RdDM pathway is related to the germline-vegetative cell communication that is thought to involve the activation of TEs in the vegetative nucleus and the transfer of small RNAs from the vegetative cell to the sperm cells. Given the existing methylome data from sperm and vegetative nucleus, it should be examined whether Althila methylation occurs in the sperm or vegetative nuclei, and whether AGO6 is specifically expressed in one cell. Since the authors show that the pathway operates only in inflorescences, it would be nice to relate their findings to their earlier findings about the differential regulation of DNA methylation and siRNA biogenesis in the reproductive cells.
It is already published that Athila becomes hyper-CHH methylated specifically in the pollen vegetative nucleus upon transcriptional activation (Calarco et al., Cell, 2012) . The Slotkin lab is currently examining the role of AGO6 in pollen. We currently understand where in the pollen grain AGO6 protein accumulates; however, showing this data would only lead to speculation about its function. The true key experiments to determine AGO6's function in the pollen grain are complex, requiring cell sorting of the different pollen grain nuclei at different developmental stages. These definitive and conclusive experiments in pollen are beyond the scope of this manuscript. We feel that showing an AGO6 expression pattern and loosely speculating beyond that would draw away from the concrete results and proven mechanism of this manuscript.
Referee #3:
McCue et al. EMBOJ-2014-89499 "ARGONAUTE 6 is recruited to chromatin by transposable element mRNA degradation products to establish DNA methylation".
In the present paper, the authors keep on their work to understand how a transcriptionnally active TE becomes silenced at chromatin level in Arabidopsis. Previous work from Slotkin's lab described the involvement of 21-22 nt long siRNA as well as the action of RDR6 in the transition of TE from an active to inactive states of expression (Nuthikattu et al. 2013 ddm1; fig4A-B) . The last part of this paper propose a developmental window for RDR6-RdDM activity, based mainly on AGO6 expression profil (pAGO6::AGO6-GFP). Fig5H) ; the enrichment of DNA methylation in these cells (fig5I) is not so obvious.
Although AGO6 distribution is clear (leaf versus inflorescences in Fig5C and emerging sepals and floral meristem cells in
We thank Reviewer #3 for their thoroughness and insightful comments. We have sequenced more clones for Figure 5K and added this data to reduce the confidence intervals and make the distinction in Figure 5K more clear.
This is an interesting work that extends the previous analysis performed by the same lab on RDR6-RdDM, therefore giving a more complete picture of this novel epigenetic pathway in plants. The paper is noteworthy for the technical approach, the quality of the work, and the potential new insights regarding the role of AGO6 in RDR6-RdDM. For all these reasons, I think that this is an interesting work worth publishing in EMBO J.

Major comments 1) Is there any bias in 5' base in AGO6 21-22 nt loaded siRNA?
We have added a thorough investigation of the 5' base to Figure 2 .
2) We can regret to do not have any molecular or genetic analysis data for AGO2.
We have not molecularly investigated AGO2 because another research group has already specifically tested AGO2's involvement and demonstrated that AGO2 is not involved in RDR6-RdDM (Wu et al., 2012) . We have added a sentence to this section of the manuscript to make it clear that AGO2 has been previously tested and plays no role in this process. and the IP performed in ddm1 using native anti-AGO6 antibody (figE3F)? This is quite striking in Athila6A LTR TSS and the first half region of gag/pol unit.
3) How the authors can explain the difference in the ratio of 21/22 nt observed between the Flag IP done on
We have added some explanation of the differences seen in FLAG vs native AGO6 IP-small RNA seq to the Expanded View section. Previous reports have performed AGO6 IPs of small RNAs using the AGO6 antibody and detected additional small RNAs that were not detected in the FLAG-AGO6 IP (Havecker, 2010, Plant Cell) , demonstrating that the native AGO6 antibody is known to IP small RNAs that are not in complex with AGO6. As seen in Figures E3A and 5D , the native AGO6 antibody detects more than one protein (which is cytoplasmic ( Figure 5J ) and does not interfere with ChIP ( Figure 3C ). On the other hand, the FLAG-AGO6 IP using the FLAG antibody is much cleaner (Fig E2B) ; therefore, this FLAG-IP small RNA data is used throughout the manuscript besides Figure E3 .
4) The developmental window assigned to RDR6-RdDM action in reproductive system is not strongly supported by data. The expression of Athila6A in ddm1 leaf compared to inflorescence could be a control to add.
We have added a significant amount of new data to Figure 5 to support our conclusions.
We have added the requested qRT-PCR expression analysis of ddm1 leaf vs inflorescence that Reviewer #3 requested ( Figure 5B ).
We have added several references to previously published data that shows the expression and small RNA accumulation in leaf vs inflorescence of wt Col and ddm1.
We have also added a nuclear / cytoplasmic fractioned Western blot as Figure 5J which verifies the primarily cytoplasmic cellular location of AGO6.
McCue et al -List of changes made to the revised document
1. An analysis of the 5' nucleotide of AGO6-incorporated small RNAs has been added as Figure 2J , providing insight into AGO6's selectivity for small RNAs. We have added a written section to the Results describing this new data (page 12-13), and we have added this to the Discussion section as well (page 23). 2. We have added a model to the Results section that centers on the selection of particular transcripts by AGO6 and RDR6-RdDM, rather than selection of particular small RNAs. This section is in red on page 12-13. 3. We have added AGO6 ChIP data from the ddm1 rdr6 genotype to Figure 3D , and added a corresponding sentence to the Results section. 4. We have improved our analysis of RDR6-RdDM methylation in Figure 4A -B by including AGO6 depleted and intermediate tiles as controls. We have increased the amount of explanation in the Results section (page 16). 5. We have added a reference and performed qRT-PCR of Athila6A for Figure 5 . 6. In Figure 5K we have sequenced more clones to reduce the confidence intervals of the data. 7. We have added to Figure 5 a nuclear / cytoplasmic fractioned Western blot to verify the primarily cytoplasmic location of the native AGO6 protein in wt Col inflorescences. 8. We have added a new Expanded View Figure (E4 ) that describes the correlation between publically available DNA methylation datasets and our AGO6-IPed small RNAs. We have added a corresponding section to the Results (page 17). 9. We have increased the explanation in the Results section (red sentences, page 7-8) of which small RNAs are responsible for Athila6A TSS methylation 10. We have added a reference and sentence to the Results section (page 9, in red) demonstrating that AGO2 is not involved in RDR6-RdDM. 11. We have focused on the ago6 mutant phenotype and the biological impact of RDR6-RdDM in the Discussion section on page 25. 12. We have increased our discussion of the difference between the AGO6 native antibody and the FLAG-AGO6 IPs. This discussion is located in the Figure Legend of Figure E3 . 13. We created a new Results section of pre-existing data to help the flow of the manuscript (on page 8)
In addition, we have made the corresponding changes to the Figure Legends and list of primers in Table E1 .
Lastly, we have made a number changes to increase clarity and to improve our grammar. All changes are shown as red text in the manuscript and Expanded View files. Thank you for submitting your revised manuscript for The EMBO Journal. Your study has now been seen by two of the original referees (comments included below) and as you will see they both find that all criticisms have been addressed. I am therefore happy to inform you that your manuscript has in principle been accepted for publication with us.
However before we can proceed to officially accept your manuscript and transfer all files for production I have to ask you to address the following editorial points in a final revision of the manuscript text:
-> I am afraid that our expanded view section only allows data figures and associated figure legends and that we cannot accommodate additional results and discussion. I therefore have to ask you to incorporate these two sections in the main manuscript (along with the additional literature references). In terms of manuscript length, we are not imposing limitations as such, but I would encourage you to slightly shorten both expanded text sections -if possible -when combining them with the main manuscript text.
-> Could you please also make sure that the number and nature of replicates (biological/technical) used for statistics are included in all relevant figures legends? (current missing in figs 1A, 3B and F, 4H, 5) -> As of Jan 1st 2014 every paper published in The EMBO Journal includes a 'Synopsis' to further enhance its discoverability. The synopsis consists of a short standfirst -written by the handling editor -as well as 2-5 one sentence bullet points that summarise the paper and are provided by the authors. I would therefore ask you to include your suggestions for bullet points.
-> In addition, I would encourage you to provide an image for the synopsis. This image should provide a rapid overview of the question addressed in the study but still needs to be kept fairly modest since the image size cannot exceed 550x400 pixels.
-> Please also consider changing the manuscript title along with the suggestions made by ref #2.
Given the referees' positive recommendations, I would like to invite you to submit a final revision of the manuscript, addressing the points outlined above. You can submit the amended manuscript file as well as synopsis image and bullet points using the link provided below. Please contact me if you have any questions.
Thank you for the opportunity to consider your manuscript for publication and congratulations on this nicely executed work! I look forward to your final revision.
REFEREE REPORTS:
The authors have done a great job addressing the issues brought up in my previous review. The only suggestion I have for the authors is to revise the title. The term "mRNA degradation products" tends to refer to products of bulk mRNA decay. In this manuscript, the authors show that the mRNAs are processed into 21-22nt siRNAs, which guide AGO6 to chromatin. It is probably best not to refer to these siRNAs as mRNA degradation products.
Referee #3:
The authors have answered my previous comments in a satisfactory manner. As a result, I accept the paper for publication in EMBO J. We have moved these sections out of the expanded view material. The expanded view discussion has now been integrated into the main discussion section. We have worked to reorganize and shorten the main discussion section. The expanded view results was integrated into the Figure  Legend of Figure E1 .
-> Could you please also make sure that the number and nature of replicates (biological/technical) used for statistics are included in all relevant figures legends? (current missing in figs 1A, 3B and F, 4H, 5)
We have added this data either in the main figure legends (for ChIP) or in the Materials and Methods section when it pertains to all samples for a given technique (such as bisulfite sequencing).
-> As of Jan 1st 2014 every paper published in The EMBO Journal includes a 'Synopsis' to further enhance its discoverability. The synopsis consists of a short standfirst -written by the handling editor -as well as 2-5 one sentence bullet points that summarise the paper and are provided by the authors. I would therefore ask you to include your suggestions for bullet points.
We have contributed 5 bullet points. Feel free to edit or alter these.
We have attached a broad model as a synopsis image.
-> Please also consider changing the manuscript title along with the suggestions made by ref #2.
We altered the title based on this comment. The title is now specific to RNA degradation via RNAi.
